|
1
|
Immune-correlates analysis of an HIV-1 vaccine efficacy trial.
|
N Engl J Med
|
2012
|
12.98
|
|
2
|
Reversion of CTL escape-variant immunodeficiency viruses in vivo.
|
Nat Med
|
2004
|
6.33
|
|
3
|
Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2.
|
PLoS Pathog
|
2009
|
4.24
|
|
4
|
Antibody-dependent cellular cytotoxicity-mediating antibodies from an HIV-1 vaccine efficacy trial target multiple epitopes and preferentially use the VH1 gene family.
|
J Virol
|
2012
|
2.74
|
|
5
|
Vaccine-induced Env V1-V2 IgG3 correlates with lower HIV-1 infection risk and declines soon after vaccination.
|
Sci Transl Med
|
2014
|
2.47
|
|
6
|
The restriction factors of human immunodeficiency virus.
|
J Biol Chem
|
2012
|
2.36
|
|
7
|
Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV.
|
Cell Host Microbe
|
2011
|
2.11
|
|
8
|
Animal models for HIV/AIDS research.
|
Nat Rev Microbiol
|
2012
|
1.71
|
|
9
|
ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.
|
PLoS Pathog
|
2012
|
1.60
|
|
10
|
A nonfucosylated variant of the anti-HIV-1 monoclonal antibody b12 has enhanced FcγRIIIa-mediated antiviral activity in vitro but does not improve protection against mucosal SHIV challenge in macaques.
|
J Virol
|
2012
|
1.29
|
|
11
|
Inhibitory TCR coreceptor PD-1 is a sensitive indicator of low-level replication of SIV and HIV-1.
|
J Immunol
|
2009
|
1.27
|
|
12
|
Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity.
|
Proc Natl Acad Sci U S A
|
2014
|
1.26
|
|
13
|
FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial.
|
J Clin Invest
|
2014
|
1.18
|
|
14
|
KIR polymorphisms modulate peptide-dependent binding to an MHC class I ligand with a Bw6 motif.
|
PLoS Pathog
|
2011
|
1.14
|
|
15
|
Immunization with single-cycle SIV significantly reduces viral loads after an intravenous challenge with SIV(mac)239.
|
PLoS Pathog
|
2009
|
1.12
|
|
16
|
A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assays.
|
J Virol
|
2012
|
1.06
|
|
17
|
Tetherin/BST-2 antagonism by Nef depends on a direct physical interaction between Nef and tetherin, and on clathrin-mediated endocytosis.
|
PLoS Pathog
|
2013
|
1.05
|
|
18
|
A panel of IgG1 b12 variants with selectively diminished or enhanced affinity for Fcγ receptors to define the role of effector functions in protection against HIV.
|
J Virol
|
2011
|
0.99
|
|
19
|
Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.
|
J Virol
|
2010
|
0.99
|
|
20
|
Selective downregulation of rhesus macaque and sooty mangabey major histocompatibility complex class I molecules by Nef alleles of simian immunodeficiency virus and human immunodeficiency virus type 2.
|
J Virol
|
2008
|
0.96
|
|
21
|
Selective downmodulation of HLA-A and -B by Nef alleles from different groups of primate lentiviruses.
|
Virology
|
2007
|
0.92
|
|
22
|
KIR3DL01 recognition of Bw4 ligands in the rhesus macaque: maintenance of Bw4 specificity since the divergence of apes and Old World monkeys.
|
J Immunol
|
2014
|
0.90
|
|
23
|
Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C*03:04 and modulate primary natural killer cell function.
|
AIDS
|
2014
|
0.89
|
|
24
|
Envelope-modified single-cycle simian immunodeficiency virus selectively enhances antibody responses and partially protects against repeated, low-dose vaginal challenge.
|
J Virol
|
2010
|
0.84
|
|
25
|
Comparison of plasma viremia and antibody responses in macaques inoculated with envelope variants of single-cycle simian immunodeficiency virus differing in infectivity and cellular tropism.
|
J Virol
|
2007
|
0.82
|
|
26
|
Tetherin upregulation in simian immunodeficiency virus-infected macaques.
|
J Virol
|
2013
|
0.82
|
|
27
|
Adaptation of human and simian immunodeficiency viruses for resistance to tetherin/BST-2.
|
Curr HIV Res
|
2012
|
0.78
|
|
28
|
Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes.
|
J Immunol Methods
|
2011
|
0.78
|
|
29
|
Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines.
|
Retrovirology
|
2011
|
0.77
|
|
30
|
PRA1 co-localizes with envelope but does not influence primate lentivirus production, infectivity or envelope incorporation.
|
J Gen Virol
|
2005
|
0.76
|
|
31
|
Promoting sexual health to young people to reduce STIs.
|
Nurs Times
|
2006
|
0.75
|
|
32
|
Sexual health matters to all practitioners.
|
Br J Nurs
|
2003
|
0.75
|